tiprankstipranks
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
PHAT
Phathom Pharmaceuticals
RESEARCH TOOLSreports
Want to see PHAT full AI Analyst Report?

Phathom Pharmaceuticals (PHAT) Income Statement

589 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q4 2025), Phathom Pharmaceuticals's total revenue was $57.58M, an increase of 94.12% from the same quarter last year. In Q4, Phathom Pharmaceuticals's net income was $-21.15M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 175.11M$ 55.25M$ 682.00K$ 0.00$ 0.00
Gross Profit
$ 152.51M$ 47.28M$ 515.00K$ -620.00K$ -521.00K
Operating Expenses
$ 312.50M$ 324.75M$ 167.83M$ 171.82M$ 134.56M
Depreciation and Amortization
$ 633.00K$ 795.00K$ 575.00K$ 620.00K$ 521.00K
EBITDA
$ -152.50M$ -261.52M$ -159.05M$ -169.80M$ -136.57M
Operating Income
$ -159.99M$ -277.47M$ -167.31M$ -172.44M$ -135.08M
Other Income/Expenses
$ -61.26M$ -56.86M$ -34.28M$ -25.28M$ -8.80M
Pretax Income
$ -221.25M$ -334.33M$ -201.59M$ -197.72M$ -143.88M
Net Income
$ -221.25M$ -334.33M$ -201.59M$ -197.72M$ -143.88M
Per Share Metrics
Basic EPS
$ -3.03$ -5.29$ -3.93$ -5.70$ -4.00
Diluted EPS
$ -3.03$ -5.29$ -3.93$ -5.70$ -4.00
Weighted Average Shares Outstanding
 72.92M 63.18M 51.29M 39.12M 37.00M
Weighted Average Shares Outstanding (Diluted)
 72.92M 63.18M 51.29M 39.12M 37.00M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History